IL4 and arthritic joint disease: In zymosan A‐induced arthritis (ZIA) mice, intravenous injection of miR‐21/IL‐4 NPs balanced the M1 and M2 macrophage phenotypes, suppressed inflammatory cell infiltration, and reduced synovial thickening, effectively alleviating arthritis symptoms.